Atlas Trials

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Clinical trial NCT03051516 · TERMINATED

Trial details

NCT number
NCT03051516
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
High Grade Anal Canal Intraepithelial NeoplasiaHigh Grade Vulvar Squamous Intraepithelial Lesion
Start date
2017-08-01
Primary completion
2022-12-31
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.